相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Effects of Aging on the Regulation of Tubular I-ca by Caveolin in Mouse Ventricular Myocytes
Cherrie H. T. Kong et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2018)
Heart Disease and Stroke Statistics-2018 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2018)
Effect of glucose-lowering therapies on heart failure
Michael Nassif et al.
NATURE REVIEWS CARDIOLOGY (2018)
Illuminating cell signaling with genetically encoded FRET biosensors in adult mouse cardiomyocytes
Gopireddy Raghavender Reddy et al.
JOURNAL OF GENERAL PHYSIOLOGY (2018)
Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction
Qingtong Wang et al.
CIRCULATION (2017)
Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes
Csaba Matyas et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Cross-Talk Between Insulin Signaling and G Protein-Coupled Receptors
Qin Fu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction Targeted Metabolomic Profiling in the RELAX Trial
Hanghang Wang et al.
JAMA CARDIOLOGY (2017)
Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G
Peter P. Rainer et al.
CARDIOVASCULAR RESEARCH (2016)
Genetically Encoded Biosensors Reveal PKA Hyperphosphorylation on the Myofilaments in Rabbit Heart Failure
Federica Barbagallo et al.
CIRCULATION RESEARCH (2016)
Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G I Oxidation
Oleksandra Prysyazhna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes
Andrea M. Isidori et al.
CARDIOVASCULAR RESEARCH (2015)
Insulin induces IRS2-dependent and GRK2-mediated β2AR internalization to attenuate βAR signaling in cardiomyocytes
Qin Fu et al.
CELLULAR SIGNALLING (2015)
Microdomain Switch of cGMP-Regulated Phosphodiesterases Leads to ANP-Induced Augmentation of β-Adrenoceptor-Stimulated Contractility in Early Cardiac Hypertrophy
Ruwan K. Perera et al.
CIRCULATION RESEARCH (2015)
Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway
Claire Y. Zhao et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
Dong I. Lee et al.
NATURE (2015)
Sildenafil treatment attenuates ventricular remodeling in an experimental model of aortic regurgitation
Kristian Eskesen et al.
SPRINGERPLUS (2015)
Fourth-Generation Epac-Based FRET Sensors for cAMP Feature Exceptional Brightness, Photostability and Dynamic Range: Characterization of Dedicated Sensors for FLIM, for Ratiometry and with High Affinity
Jeffrey Klarenbeek et al.
PLOS ONE (2015)
THERAPY OF ENDOCRINE DISEASE Effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis
Daniele Santi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling
Saisudha Koka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Insulin Inhibits Cardiac Contractility by Inducing a Gi-Biased β2-Adrenergic Signaling in Hearts
Qin Fu et al.
DIABETES (2014)
Dipeptidyl peptidase-4 inhibitors and heart failure: A meta-analysis of randomized clinical trials
M. Monami et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Emerging mechanisms of T-tubule remodelling in heart failure
Ang Guo et al.
CARDIOVASCULAR RESEARCH (2013)
Epac2 Mediates Cardiac β1-Adrenergic-Dependent Sarcoplasmic Reticulum Ca2+ Leak and Arrhythmia
Laetitia Pereira et al.
CIRCULATION (2013)
Cardiotoxic and Cardioprotective Features of Chronic β-Adrenergic Signaling
Xiaoying Zhang et al.
CIRCULATION RESEARCH (2013)
Phosphodiesterase Type 3A Regulates Basal Myocardial Contractility Through Interacting With Sarcoplasmic Reticulum Calcium ATPase Type 2a Signaling Complexes in Mouse Heart
Sanja Beca et al.
CIRCULATION RESEARCH (2013)
Myocardial Loss of IRS1 and IRS2 Causes Heart Failure and Is Controlled by p38α MAPK During Insulin Resistance
Yajuan Qi et al.
DIABETES (2013)
Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice
Saisudha Koka et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Margaret M. Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Chronic treatment with long acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in Type 2 diabetic hearts
Saisudha Koka et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging
Elisa Giannetta et al.
CIRCULATION (2012)
Anti-Inflammatory and Cardioprotective Effects of Tadalafil in Diabetic Mice
Amit Varma et al.
PLOS ONE (2012)
cGMP Signals Modulate cAMP Levels in a Compartment-Specific Manner to Regulate Catecholamine-Dependent Signaling in Cardiac Myocytes
Alessandra Stangherlin et al.
CIRCULATION RESEARCH (2011)
A Critical Function for Ser-282 in Cardiac Myosin Binding Protein-C Phosphorylation and Cardiac Function
Sakthivel Sadayappan et al.
CIRCULATION RESEARCH (2011)
Comparison of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction Among Those With Versus Without Diabetes Mellitus
David Aguilar et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
PDE5A suppression of acute β-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation
Dong I. Lee et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Differential Regulation of Proteasome Function in Isoproterenol-Induced Cardiac Hypertrophy
Oliver Drews et al.
CIRCULATION RESEARCH (2010)
Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition
Norimichi Koitabashi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
β2-Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation
Viacheslav O. Nikolaev et al.
SCIENCE (2010)
The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus
T. Radovits et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Sildenafil Stops Progressive Chamber, Cellular, and Molecular Remodeling and Improves Calcium Handling and Function in Hearts With Pre-Existing Advanced Hypertrophy Caused by Pressure Overload
Takahiro Nagayama et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
The role of membrane microdomains in shaping beta(2)-adrenergic receptor-mediated cAMP dynamics
Lisa M. DiPilato et al.
MOLECULAR BIOSYSTEMS (2009)
Arrhythmogenic effects of β2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load
Jaime DeSantiago et al.
CIRCULATION RESEARCH (2008)
Signaling from β1- and β2-adrenergic receptors is defined by differential interactions with PDE4
Wito Richter et al.
EMBO JOURNAL (2008)
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure
Michael R. MacDonald et al.
EUROPEAN HEART JOURNAL (2008)
Design of fluorescence resonance energy transfer (FRET)-based cGMP indicators:: a systematic approach
Michael Russwurm et al.
BIOCHEMICAL JOURNAL (2007)
Home inotropic therapy in children
Alexandria M. Berg et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)
Compartmentalization of cardiac β-adrenergic inotropy modulation by phosphodiesterase type 5
Eiki Takimoto et al.
CIRCULATION (2007)
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
Jinyong Luo et al.
NATURE PROTOCOLS (2007)
Cardiac myosin binding protein C phosphorylation is cardioprotective
Sakthivel Sadayappan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters
Michael D. Allen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Trends in prevalence and outcome of heart failure with preserved ejection fraction
Theophilus E. Owan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure
JF Price et al.
JOURNAL OF CARDIAC FAILURE (2006)
Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study
SH Simpson et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis - Implication in heart failure
B Ding et al.
CIRCULATION (2005)
Visualization of synaptic Ca2+/calmodulin-dependent protein kinase II activity in living neurons
K Takao et al.
JOURNAL OF NEUROSCIENCE (2005)
Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies
S Minamisawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)